PHASE Scientific Americas Announces INDICAID Health™ At-Home Test Kits and Digital Health Platform

PHASE Scientific Americas (PHASE Scientific), a fast-growing, global biomedical company developing innovative solutions to revolutionize healthcare diagnostics, announces INDICAID health™, its new line of at-home health tests and digital health experiences. INDICAID health™ meets patients where they are by letting them test from the comfort of their own home and receive care that aligns with their personal situations and suits their lifestyle best.

Integration of AI and E-Prescriptions Transform the European Online Pharmacy Landscape, While Regulatory Challenges Persist – ResearchAndMarkets.com

The "European Online Pharmacy Market (by Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)" report has been added to ResearchAndMarkets.com's offering. The European online pharmacy market ...

Aptar Digital Health Unveils iPUMP® in France: The Pioneering Allergy Management Companion from Stallergenes Greer

Crystal Lake, Illinois, OCTOBER 24, 2023 - Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Progr…

Altoida’s AR-based Digital Cognitive and Functional Assessment Correlates with Standard Neuropsychological Tests in MCI and Healthy Volunteers

Altoida, a pioneer in developing digital biomarkers of neurological disease using augmented reality (AR) and machine learning (ML), today announced results from a 188-participant study demonstrating its novel digital c...

Virtual Mental Health Platform Telemynd Expands Patient Access Through Latest Network Partnership

Telemynd, a leading virtual mental health solution, today announced its latest partnership with renowned healthcare service provider UnitedHealthcare. The venture represents the latest in a series of significant moves f...

Butterfly Network Announces 5-Year Co-Development Agreement with Forest Neurotech for Next-generation Brain Computer Interfaces Using Ultrasound-on-Chip™ Technology

Companies announce collaboration to develop the first implanted, whole-brain neural interface Powered by Butterfly’s Ultrasound-on-Chip™ technology.

DermBiont Announces First Close of $35.2 Million in a Series B Financing to Advance First-in-Class Targeted Topical Dermatological Therapeutics

Series B led by Double Point Ventures with major support from Viking Global Investors as well as other new and existing investors - - A combined $27.1 million Series B first close and $8.1 million in converting outstanding notes funds the company’s ...

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Believes Nymox Management and Board Must Be Held Accountable for Prolonged Underperformance and Egregious Governance Practices Urges Shareholders to Vote on the WHITE Proxy Card to Install New Leadership and a New Board at Upcoming Special MeetingCARS...

Ardent appoints veteran healthcare executives to senior leadership roles

Ardent Health Services today announced the appointments of Anika Gardenhire, RN, BSN, MMCI, as chief digital information officer and Joe DeSchryver as president of Ardent’s Americas Region. “We are excited to welcome ...

U.S. Defense Health Agency selects Amwell® and Leidos to power the Digital First initiative for the U.S. Military Health System

Amwell®, a leader in hybrid healthcare enablement, together with Leidos, a FORTUNE® 500 science and technology leader, was recently awarded a next-generation contract to provide a hybrid care technology platform designed to power the “Digital First” transformation of the Military Health System (MHS).